Tectonic Therapeutic, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Timothy A. Springer and TAS Partners LLC, along with Chafen Lu, have significantly increased their beneficial ownership in Tectonic Therapeutic, Inc. to 31.5% through recent share purchases.
NASDAQ
SCHEDULE 13D/A: Polaris Partners IX Reduces Stake in Tectonic Therapeutic, Timothy Springer Acquires Significant Block
A recent SEC filing reveals that Polaris Partners IX, L.P. has significantly reduced its beneficial ownership in Tectonic Therapeutic, Inc. by selling 500,000 shares, while Timothy A. Springer and TAS Partners LLC acquired the same block of shares.
NASDAQ
SCHEDULE 13D/A: Vida Ventures Fully Divests Stake in Tectonic Therapeutic, Completing Share Liquidation
Vida Ventures II, LLC and Vida Ventures II-A, LLC have reported a complete divestment of their beneficial ownership in Tectonic Therapeutic, Inc. through a series of distributions and market sales.
NASDAQ
SCHEDULE 13D/A: Tectonic Therapeutic Secures $185 Million Private Placement, Key Insiders Boost Stakes
Tectonic Therapeutic, Inc. announced the successful closing of a $185 million private placement of common stock, significantly increasing the beneficial ownership of key insiders, including Dr. Timothy A. Springer, to 29.2%.
NASDAQ
Vida Ventures II, LLC and its affiliates have filed an amended Schedule 13D, reporting a decrease in their aggregate beneficial ownership of Tectonic Therapeutic, Inc. to 5.6% due to dilution from the Issuer's recent private placement.
NASDAQ
SCHEDULE 13D/A: Polaris Funds and Terrance McGuire Amend Tectonic Therapeutic Stake Disclosure Following Share Dilution
Polaris Partners and affiliated entities, including director Terrance McGuire, have filed an amended Schedule 13D for Tectonic Therapeutic, Inc., updating their beneficial ownership percentage due to dilution from the Issuer's recent private placement.